Narcobarbital

Narcobarbital
Clinical data
ATC code
Identifiers
IUPAC name
  • 5-(2-bromoprop-2-en-1-yl)-5-isopropyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC11H15BrN2O3
Molar mass303.156 g·mol−1
3D model (JSmol)
SMILES
  • O=C1N(C(=O)NC(=O)C1(CC(\Br)=C)C(C)C)C
InChI
  • InChI=1S/C11H15BrN2O3/c1-6(2)11(5-7(3)12)8(15)13-10(17)14(4)9(11)16/h6H,3,5H2,1-2,4H3,(H,13,15,17) checkY
  • Key:WGMASVSHOSNKMF-UHFFFAOYSA-N checkY
  (verify)

Narcobarbital (Pronarcon) is a barbiturate derivative developed in 1932 by Carl Heinrich Friedrich Boedecker and Heinrich Gruber Schoneberg, assignors to the firm J. D. Riedel-E. de Haën AG, Berlin, Germany. Later, in 1937, may, was patented in United States.[1] It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.[2]


References

  1. ↑ US Patent 2080071
  2. ↑ N/A (1999). "Position Paper on availability of Veterinary Medicines agreed on 17 March 1999" (PDF (Public access)). Committee for Veterinary Medicinal Products: 3–8.



This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.